These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 33143731)

  • 1. Efficacy of Tong-Xie-Yao-Fang granule and its impact on whole transcriptome profiling in diarrhea-predominant irritable bowel syndrome patients: study protocol for a randomized controlled trial.
    Wang Y; Huang YQ; Zhu SL; Zhang CR; Chen XL; Hou QK; Liu FB
    Trials; 2020 Nov; 21(1):908. PubMed ID: 33143731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the clinical mechanism of Tong-Xie-An-Chang Decoction in the treatment of diarrheal irritable bowel syndrome based on single-cell sequencing technology.
    Tan X; Zhao XJ; Li JX; Xie CE; Pei WJ; Shi L; Kou FS; Yuan YL; Xue XX
    Medicine (Baltimore); 2020 Dec; 99(52):e23868. PubMed ID: 33350782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, multiple-blind, placebo-controlled trial.
    Liang SB; Han M; Cheng HJ; Zhang QY; Zhang NW; Jia BY; Robinson N; Liu JP
    Trials; 2022 Mar; 23(1):226. PubMed ID: 35313933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Traditional Chinese medicine (Shun-Qi-Tong-Xie Granule) for irritable bowel syndrome: study protocol for a randomised controlled trial.
    Wang XX; Luo RJ; She B; Chen Y; Guo J
    Trials; 2014 Jul; 15():273. PubMed ID: 25002196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial: Tong-Xie-Yao-Fang granules versus placebo for patients with diarrhoea-predominant irritable bowel syndrome.
    Chen M; Tang TC; Wang Y; Shui J; Xiao XH; Lan X; Yu P; Zhang C; Wang SH; Yao J; Zheng H; Huang DQ
    Aliment Pharmacol Ther; 2018 Jul; 48(2):160-168. PubMed ID: 29856472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and indication optimization of Chinese medicine (Tiao-Chang Ke-Min granules) for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized controlled trial.
    Li Q; Zhang BP; Huang SG; Ouyang WW; Xie JH; Wen ZH; Yang XB
    Trials; 2018 Jul; 19(1):367. PubMed ID: 29996882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tong-Xie-Yao-Fang alleviates diarrhea-predominant irritable bowel syndrome in rats via the GCN2/PERK-eIF2α-ATF4 signaling pathway.
    Zhang M; Zheng Y; Li X; Wu H; Liu P; Zhang K; Shi Z; Lv M; Wang F; Tang X
    Phytomedicine; 2022 Dec; 107():154350. PubMed ID: 36194974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-κB and notch signalling pathways.
    Hou Q; Huang Y; Zhu Z; Liao L; Chen X; Han Q; Liu F
    BMC Complement Altern Med; 2019 Nov; 19(1):337. PubMed ID: 31775739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tong-Xie-Yao-Fang strengthens intestinal feedback control of bile acid synthesis to ameliorate irritable bowel syndrome by enhancing bile salt hydrolase-expressing microbiota.
    Jia F; Du L; He J; Zhang Z; Hou X; Dong Q; Bian Z; Zhao L
    J Ethnopharmacol; 2024 Sep; 331():118256. PubMed ID: 38677571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chinese herbal formula Huoxiang Zhengqi for diarrhea-predominant irritable bowel syndrome (CHAIRS): a study protocol for a double-blinded randomized controlled trial.
    Guo X; Xuan M; Zheng H; Qin S; Wu H; Huang S; Wen Z
    Trials; 2021 Jul; 22(1):491. PubMed ID: 34311755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
    Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
    World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation.
    Li J; Cui H; Cai Y; Lin J; Song X; Zhou Z; Xiong W; Zhou H; Bian Y; Wang L
    Front Pharmacol; 2018; 9():1110. PubMed ID: 30323765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-marketing Re-evaluation of Tongxiening Granules () in Treatment of Diarrhea-Predominant Irritable Bowel Syndrome: A Multi-center, Randomized, Double-Blind, Double-Dummy and Positive Control Trial.
    Tang XD; Zhang SS; Hou XH; Li ZH; Chen SN; Feng PM; Yang XN; Li HZ; Wu JQ; Xia PJ; Yang XJ; Zhou HJ; Wang HY; Ai YW; Li K
    Chin J Integr Med; 2019 Dec; 25(12):887-894. PubMed ID: 31292845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Effect of Chang'an I Recipe ( I ) on Irritable Bowel Syndrome with Diarrhea: A Multicenter Randomized Double-Blind Placebo-Controlled Clinical Trial.
    Tang XD; Lu B; Li ZH; Wei W; Meng LN; Li BS; Tang ZP; Gao R; Wang FY; Lu F; Bian LQ; Zhao YP; Wang P; Zhang YQ
    Chin J Integr Med; 2018 Sep; 24(9):645-652. PubMed ID: 27487786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of Qinghua Zhixie Decoction against diarrhea-predominate irritable bowel syndrome: A protocol for a randomized controlled trial.
    Ji L; Zhao X; Zhang Y; Zhao P; Gong R; Li F; Huang H
    Medicine (Baltimore); 2022 Mar; 101(9):e28895. PubMed ID: 35244043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tong Xie Yao Fang relieves irritable bowel syndrome in rats via mechanisms involving regulation of 5-hydroxytryptamine and substance P.
    Yin Y; Zhong L; Wang JW; Zhao XY; Zhao WJ; Kuang HX
    World J Gastroenterol; 2015 Apr; 21(15):4536-46. PubMed ID: 25914462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acupuncture combined with Tongxieyaofang for diarrhea-type irritable bowel syndrome: A protocol for meta-analysis.
    Li YL; Yao CJ; Lei R; Xie F; Xiong Q; Luo LH; Feng PM
    Medicine (Baltimore); 2020 Nov; 99(48):e23457. PubMed ID: 33235133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Tong-Xie-Yao-Fang combined with Si-Ni-San for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Jiang J; Chen Y; Hu Z; Li H; Ye J; Yu Z; Tang H
    Medicine (Baltimore); 2021 Mar; 100(11):e25198. PubMed ID: 33726014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of Chinese medicine JCM-16021 for diarrhea-predominant irritable bowel syndrome: study protocol for a multi-center, randomized, double-blind, placebo controlled clinical trial.
    Zheng Y; Ching J; Cheng CW; Lam WC; Chan KL; Zhang X; Lam PY; Wu XY; Zhong LLD; Cao PH; Lo CW; Cheong PK; Lin Z; Koh M; Wu J; Bian ZX
    Chin Med; 2021 Nov; 16(1):117. PubMed ID: 34774080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of diarrhea-predominant irritable bowel syndrome with traditional Chinese herbal medicine: a randomized placebo-controlled trial.
    Leung WK; Wu JC; Liang SM; Chan LS; Chan FK; Xie H; Fung SS; Hui AJ; Wong VW; Che CT; Sung JJ
    Am J Gastroenterol; 2006 Jul; 101(7):1574-80. PubMed ID: 16863563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.